Treo Ventures

Exciting Milestone News! We are extremely proud to share the incredible news that we’ve successfully implanted our innovative Chronic Migraine System in the world’s first patients. This milestone marks a significant step forward in our mission to provide relief to those battling the challenges of this debilitating disease. A huge shoutout to the incredible ShiraTronics team! Every individual, from our dedicated office staff to our brilliant engineers, played a vital role in making this groundbreaking achievement a reality. Kudos to our outstanding clinical team for their leadership and tireless efforts in the field throughout this endeavor. This accomplishment is a testament to the passion and commitment of each and every team member. A special thank you goes out to our Australian investigators and their teams, who have been instrumental in this journey. Your expertise and collaboration have played a pivotal role in turning the ShiraTronics vision into a reality. To everyone who has been a part of this journey, THANK YOU! Your support and hard work have propelled us forward in our mission to make a positive impact on the lives of individuals living with chronic migraine. Read the press release here: https://lnkd.in/gcffgYDz #neuromodulation #migraine #chronicmigraine This communication contains information about a device not yet approved in the United States for commercial use. ShiraTronics makes no claims of safety or effectiveness. Matthew Green, MD | James Yue, MD | Marc Russo, MD | John Salmon, MD | Fred Ecklund | Jing Li | Nicole Schnaus, PT | Elliott Hough | Patrick Cecka | Mitchell Tramp | Andrew Sowada, MBA